GL Pharm Tech (XKRX:204840) Net Change in Cash : ₩122 Mil (TTM As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is GL Pharm Tech Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

GL Pharm Tech's Net Change in Cash for the three months ended in Dec. 2024 was ₩-2,408 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was ₩122 Mil.

GL Pharm Tech Net Change in Cash Historical Data

The historical data trend for GL Pharm Tech's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GL Pharm Tech Net Change in Cash Chart

GL Pharm Tech Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Change in Cash

Get a 7-Day Free Trial

9,165.52

-3,300.95

-652.60

-503.67

121.95

GL Pharm Tech Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Net Change in Cash	Get a 7-Day Free Trial															-656.11	7,758.56	-5,578.53	349.91	-2,407.99

GL Pharm Tech Net Change in Cash Calculation

GL Pharm Tech's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-4647.589	+	-1580.195	+	6349.732	+	0
	=	122

GL Pharm Tech's Net Change in Cash for the quarter that ended in Dec. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -1866.794 + -401.635 + -139.558 + 0

= -2,408

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩122 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GL Pharm Tech Net Change in Cash Related Terms
Thank you for viewing the detailed overview of GL Pharm Tech's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

GL Pharm Tech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GL Pharm Tech Corp (XKRX:204840) » Definitions » Net Change in Cash

Comparable Companies

XKRX:009300 XKRX:002800 XKRX:003120 XKRX:054670 XKRX:131030 XKRX:002720 XKRX:066700 XKRX:183490 XKRX:072020 XKRX:004310 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA

Traded in Other Exchanges

N/A

Address

137, Sagimakgol-ro, Jungwon-gu, No 714 Jungang Induspia V, Gyeonggi-do, Seongnam, KOR, 462713

Website

http://www.glpt.co.kr

GL Pharm Tech Corp is engaged in developing and marketing pharmaceutical products. It offers products including Incrementally Modified Drugs, Generic Drug and G-SOREN Tab. It also provides generic drugs for cardiovascular, gastric, diabetes, CNS, and respiratory diseases.

GL Pharm Tech Headlines

No Headlines